Finanzwire Finanzwire
Basculer en Français
10866 Companies
236216 Keywords
165139 Articles
126676 Press releases
Headlines Articles Press releases Kedrion Remove
  1. Home
  2. Companies
  3. Kedrion
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 11/27/2025 at 10:10, 8 months 24 days ago

    EMA Grants Orphan Drug Designation to Kedrion's Treatment for ACP

    Biopharmaceutical Innovation Kedrion Orphan Drug EMA Approval Iron Metabolism
  • PRESS RELEASE

    published on 11/27/2025 at 10:05, 8 months 24 days ago

    European Medicines Agency (EMA) grants Orphan Drug Designation to Kedrion's plasma-derived treatment for Congenital Aceruloplasminemia, a rare genetic disorder of iron metabolism

    Kedrion's plasma-derived treatment for Congenital Aceruloplasminemia granted Orphan Drug Designation by EMA, highlighting commitment to rare disease innovation
    Orphan Drug Designation Rare Disease Kedrion Plasma-derived Treatment Congenital Aceruloplasminemia
    Logo of Kedrion
  • BRIEF

    published on 11/06/2025 at 14:50, 9 months 15 days ago

    Kedrion Highlights Secondary Immunodeficiencies at IPIC 2025

    Kedrion Biopharma Hematologic Malignancies Secondary Immunodeficiencies IPIC 2025 Immunoglobulin Therapy
  • PRESS RELEASE

    published on 11/06/2025 at 14:45, 9 months 15 days ago

    Secondary Immunodeficiencies in the spotlight at IPIC 2025: Kedrion champions innovation and patient care

    Kedrion Biopharma shines spotlight on Secondary Immunodeficiencies at IPIC 2025, highlighting challenges and advances in patient care
    Innovation Patient Care Kedrion Biopharma Secondary Immunodeficiencies IPIC 2025
    Logo of Kedrion
Accesswire
  • Published on 08/21/2026 at 13:30, 5 hours 12 minutes ago

    BULGOLD Announces Filing Of Financial Results For the Six Months Ended June 30, 2026

  • Published on 08/21/2026 at 02:30, 16 hours 12 minutes ago

    PPX Mining Announces Completion of Debt Settlement

  • Published on 08/21/2026 at 00:00, 18 hours 42 minutes ago

    Apex Confirms Favourable Monazite and Bastnaesite Mineralogy at the Rift Rare Earth Project

  • Published on 08/20/2026 at 23:00, 19 hours 42 minutes ago

    EQ Inc. Reports Second Quarter 2026 Financial Results

  • Published on 08/20/2026 at 22:00, 20 hours 42 minutes ago

    Gold Terra Closes Third and Final Tranche of Its LIFE Offering for Gross Proceeds of Approximately C$10.1 M

View all ACCESSWIRE
EQS Group
  • Published on 08/21/2026 at 18:14, 27 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 08/21/2026 at 17:27, 1 hour 15 minutes ago

    EQS-Adhoc: PSI Adjusts Its Forecast for Fiscal Year 2026 in Light of Economic Uncertainties in Europe

  • Published on 08/21/2026 at 16:30, 2 hours 12 minutes ago

    BL Networks (BLNWX) Details Major Global Infrastructure Expansion and Upgrades

  • Published on 08/21/2026 at 15:23, 3 hours 18 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc

  • Published on 08/21/2026 at 15:22, 3 hours 20 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.

View all EQS
Les Echos
  • Published on 08/21/2026 at 08:30, 10 hours 12 minutes ago

    Thales issues a €1bn bond

  • Published on 08/18/2026 at 11:15, 3 days 7 hours ago

    GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026

  • Published on 08/17/2026 at 19:45, 3 days 22 hours ago

    Aéroports de Paris S.A - July 2026 traffic figures

  • Published on 08/17/2026 at 17:45, 4 days ago

    Weekly share buyback

  • Published on 08/17/2026 at 08:33, 4 days 10 hours ago

    Covivio - Information on Treasury shares transactions between August 10th, 2026 and August 11th, 2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy